News
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
By Ben Ezeamalu LAGOS (Reuters) -Nigerian manufacturer Codix Bio Ltd plans to make millions of HIV and Malaria test kits at ...
The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained ...
The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...
(Reuters) -The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences' lenacapavir, a twice-yearly injection ...
But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
University of Michigan researchers have uncovered new details of the process that HIV uses to hijack cells' transportation ...
The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results